These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7537468)

  • 1. Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Saitta A; Caputi AP
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1412-7. PubMed ID: 7537468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-selectin involvement in the pathogenesis of splanchnic artery occlusion shock.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Ammendolia L; Caputi AP
    Eur J Pharmacol; 1995 Jan; 272(2-3):223-9. PubMed ID: 7536163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Minutoli L; Ferlito M; Saitta A; Caputi AP
    Eur J Pharmacol; 1998 Nov; 361(1):101-8. PubMed ID: 9851547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Ioculano M; Calapai G; Zingarelli B; Saitta A; Campo GM; Rizzo A; Caputi AP
    Circ Shock; 1992 Jul; 37(3):236-44. PubMed ID: 1423915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
    Squadrito F; Guarini S; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Cucinotta D; Bazzani C; Cainazzo MM; Mioni C; Bertolini A; Caputi AP
    Br J Pharmacol; 1999 Oct; 128(3):816-22. PubMed ID: 10516667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.
    Squadrito F; Altavilla D; Canale P; Ioculano MP; Campo GM; Ammendolia L; Squadrito G; Saitta A; Calapai G; Caputi AP
    Br J Pharmacol; 1994 Nov; 113(3):912-6. PubMed ID: 7858885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate.
    Canale P; Squadrito F; Zingarelli B; Altavilla D; Ioculano M; Campo GM; Caputi AP
    Pharmacol Res; 1993; 27(1):61-71. PubMed ID: 8456059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Canale P; Ioculano M; Campo GM; Ammendolia L; Ferlito M; Zingarelli B; Squadrito G; Saitta A
    Br J Pharmacol; 1994 Dec; 113(4):1153-8. PubMed ID: 7889268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Zingarelli B; Campo GM; Urna G; Sardella A; Squadrito G; Caputi AP
    Agents Actions; 1994 Oct; 42(3-4):128-34. PubMed ID: 7879698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
    Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock.
    Altavilla D; Guarini S; Bitto A; Mioni C; Giuliani D; Bigiani A; Squadrito G; Minutoli L; Venuti FS; Messineo F; De Meo V; Bazzani C; Squadrito F
    Shock; 2006 May; 25(5):500-6. PubMed ID: 16680015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Campo GM; Arlotta M; Grimaldi S; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):498-504. PubMed ID: 10385251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Ammedolia L; Arlotta M; Saitta A; Caputi AP
    Br J Pharmacol; 1997 Jan; 120(2):333-9. PubMed ID: 9117128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock.
    Cuzzocrea S; Nocentini G; Di Paola R; Mazzon E; Ronchetti S; Genovese T; Muià C; Caputi AP; Riccardi C
    J Leukoc Biol; 2004 Nov; 76(5):933-40. PubMed ID: 15316036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.
    Squadrito F; Altavilla D; Ammendolia L; Squadrito G; Campo GM; Sperandeo A; Canale P; Ioculano M; Saitta A; Caputi AP
    Br J Pharmacol; 1995 Jun; 115(3):395-400. PubMed ID: 7582448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Arcoraci V; Minutoli L; Saitta A; Caputi AP
    Br J Pharmacol; 1997 Aug; 121(8):1782-8. PubMed ID: 9283718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.
    Cuzzocrea S; Mazzon E; Dugo L; Caputi AP; Aston K; Riley DP; Salvemini D
    Br J Pharmacol; 2001 Jan; 132(1):19-29. PubMed ID: 11156557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock.
    Cuzzocrea S; De Sarro G; Costantino G; Ciliberto G; Mazzon E; De Sarro A; Caputi AP
    J Leukoc Biol; 1999 Sep; 66(3):471-80. PubMed ID: 10496318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
    Cuzzocrea S; Di Paola R; Mazzon E; Genovese T; Muià C; Caputi AP
    Shock; 2004 Oct; 22(4):340-6. PubMed ID: 15377889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Canale P; Rossi F; Saitta A; Caputi AP
    Br J Pharmacol; 1996 Sep; 119(1):23-8. PubMed ID: 8872352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.